Literature DB >> 22499813

Implications of a newer Framingham model.

Cait O'Sullivan.   

Abstract

Mesh：

Year:  2012        PMID： 22499813      PMCID： PMC3325446     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Authors:  Jacques Genest; Ruth McPherson; Jiri Frohlich; Todd Anderson; Norm Campbell; André Carpentier; Patrick Couture; Robert Dufour; George Fodor; Gordon A Francis; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence Leiter; Gary F Lewis; Eva Lonn; G B John Mancini; Dominic Ng; Glen J Pearson; Allan Sniderman; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

3.  Puzzling result.

Authors:  Christian Dufour
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

4.  Reliable tool.

Authors:  Marina Sapozhnikov
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

5.  The population effects of the global cardiovascular risk model in United States adults: findings from the National Health and Nutrition Surveys, 2005-2006.

Authors:  Matthew C Tattersall; Kunal N Karmali; Ronald E Gangnon; Jon G Keevil
Journal:  J Clin Lipidol       Date:  2011-03-02       Impact factor: 4.766

Review 6.  Practical use of the Framingham risk score in primary prevention: Canadian perspective.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2011-04       Impact factor: 3.275

7.  The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.

Authors:  David W J Armstrong; Daniel Brouillard; Murray F Matangi
Journal:  Can J Cardiol       Date:  2011 Mar-Apr       Impact factor: 5.223

8.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.